Reference
Chaudhry M, et al. Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenstrom's macroglobulinemia. Blood 130 (Suppl. 1): 1880, Dec 2017 [abstract] - USA
Rights and permissions
About this article
Cite this article
Rituximab. Reactions Weekly 1695, 324 (2018). https://doi.org/10.1007/s40278-018-44151-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44151-x